POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Nutritional Supplement to Support People With Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trial in Chinese Healthy Volunteers of GB222
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Green Tea Combined With Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- NA
Real World Observational Study of Pembrolizumab for Chinese Advanced NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
- Status
- UNKNOWN
- Phase
- PHASE2
Expanded Access to Ensartinib for Participants With ALK+ NSCLC
- Status
- AVAILABLE
- Phase
- N/A
Sintilimab Combined With Docetaxel for Standard Chemotherapy Failure Non-driver Gene Mutation Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
- Status
- UNKNOWN
- Phase
- N/A
Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)
- Status
- UNKNOWN
- Phase
- PHASE2
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of JAB-3312 in Adult Patients With Advanced Solid Tumors in China
- Status
- COMPLETED
- Phase
- PHASE1
A Study of SHR-1210 in Combination With Carboplatin+Paclitaxel-albumin in Subjects With Resectable NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Non-Viral TCR Gene Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2